Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02553174 · ClinicalTrials.gov registry record
AKI in Thoracic and Abdominal Surgery
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- 50
- Enrollment target
NCT02553174 is a clinical trial that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 50 participants.
The verdict
NCT02553174 was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The study will investigate the role of NSAIDs in the development of AKI in patients undergoing high-risk abdominal or thoracic surgery. The investigators hypothesize that the use of new urinary biomarkers will allow earlier detection of AKI than the current gold standard, i.e. changes in serum creatinine and/or urine output.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-06-01 |
| Est. Completion | 2018-03-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02553174
The ClinicalTrials.gov registry entry for NCT02553174 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02553174 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02553174 about?
NCT02553174 is a clinical study titled "AKI in Thoracic and Abdominal Surgery". The study will investigate the role of NSAIDs in the development of AKI in patients undergoing high-risk abdominal or thoracic surgery. The investigators hypothesize that the use of new urinary biomarkers will allow earlier detection of AKI than the current gold standard, i.e. changes in serum creat...
What is the current status of trial NCT02553174?
This trial is currently terminated. The enrollment target is 50 participants. The study started on 2016-06-01. Estimated completion is 2018-03-23.
Who is sponsoring clinical trial NCT02553174?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.